Company Details
connecting-psychiatry
None employees
556
62133
boehringer-ingelheim.com
0
CON_2500690
In-progress


Connecting Psychiatry Company CyberSecurity Posture
boehringer-ingelheim.comConnecting Psychiatry by Boehringer Ingelheim is a comprehensive resource hub for mental health professionals. It offers high-quality, up-to-date content on various psychiatric conditions, including schizophrenia, bipolar disorder, and MDD. The platform features articles, videos, infographics, and expert insights to support clinical practice and patient care. It aims to enhance understanding and treatment of mental health disorders through accessible and reliable information.
Company Details
connecting-psychiatry
None employees
556
62133
boehringer-ingelheim.com
0
CON_2500690
In-progress
Between 750 and 799

Connecting Psychiatry Global Score (TPRM)XXXX



No incidents recorded for Connecting Psychiatry in 2026.
No incidents recorded for Connecting Psychiatry in 2026.
No incidents recorded for Connecting Psychiatry in 2026.
Connecting Psychiatry cyber incidents detection timeline including parent company and subsidiaries

Connecting Psychiatry by Boehringer Ingelheim is a comprehensive resource hub for mental health professionals. It offers high-quality, up-to-date content on various psychiatric conditions, including schizophrenia, bipolar disorder, and MDD. The platform features articles, videos, infographics, and expert insights to support clinical practice and patient care. It aims to enhance understanding and treatment of mental health disorders through accessible and reliable information.


Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 24,000+ professionals worldw

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread acro

The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating wit

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purp

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Acc

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worl
We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing t

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrol
.png)
Headway, a tech-enabled network of mental health providers, has achieved a major milestone: it is now serving patients in all 50 states and the District of...
This epidemic has mounting implications for the workplace, with employers and business leaders seeking ways to support social connection,...
From reducing stress to improving sleep, spending time outdoors can work wonders for our minds.
The United States faces a nationwide youth mental health crisis. The time is right and the need has never been more apparent to discuss proven and...
A Denver program is helping people capture images and write narratives to help in their mental health recovery.
With an advancement of digital technology, excessive screen time has become a grave concern. This has pushed researchers and practitioners...
There is no factual link between mental illness and violence against others. In fact, people with mental health disorders are more likely to be victims of a...

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of Connecting Psychiatry is https://pro.boehringer-ingelheim.com/connecting-psychiatry/.
According to Rankiteo, Connecting Psychiatry’s AI-generated cybersecurity score is 755, reflecting their Fair security posture.
According to Rankiteo, Connecting Psychiatry currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, Connecting Psychiatry has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.
According to Rankiteo, Connecting Psychiatry is not certified under SOC 2 Type 1.
According to Rankiteo, Connecting Psychiatry does not hold a SOC 2 Type 2 certification.
According to Rankiteo, Connecting Psychiatry is not listed as GDPR compliant.
According to Rankiteo, Connecting Psychiatry does not currently maintain PCI DSS compliance.
According to Rankiteo, Connecting Psychiatry is not compliant with HIPAA regulations.
According to Rankiteo,Connecting Psychiatry is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Connecting Psychiatry operates primarily in the Mental Health Care industry.
Connecting Psychiatry employs approximately None employees people worldwide.
Connecting Psychiatry presently has no subsidiaries across any sectors.
Connecting Psychiatry’s official LinkedIn profile has approximately 556 followers.
Connecting Psychiatry is classified under the NAICS code 62133, which corresponds to Offices of Mental Health Practitioners (except Physicians).
No, Connecting Psychiatry does not have a profile on Crunchbase.
Yes, Connecting Psychiatry maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/connecting-psychiatry.
As of January 22, 2026, Rankiteo reports that Connecting Psychiatry has not experienced any cybersecurity incidents.
Connecting Psychiatry has an estimated 5,278 peer or competitor companies worldwide.
Total Incidents: According to Rankiteo, Connecting Psychiatry has faced 0 incidents in the past.
Incident Types: The types of cybersecurity incidents that have occurred include .
.png)
Backstage is an open framework for building developer portals, and @backstage/backend-defaults provides the default implementations and setup for a standard Backstage backend app. Prior to versions 0.12.2, 0.13.2, 0.14.1, and 0.15.0, the `FetchUrlReader` component, used by the catalog and other plugins to fetch content from URLs, followed HTTP redirects automatically. This allowed an attacker who controls a host listed in `backend.reading.allow` to redirect requests to internal or sensitive URLs that are not on the allowlist, bypassing the URL allowlist security control. This is a Server-Side Request Forgery (SSRF) vulnerability that could allow access to internal resources, but it does not allow attackers to include additional request headers. This vulnerability is fixed in `@backstage/backend-defaults` version 0.12.2, 0.13.2, 0.14.1, and 0.15.0. Users should upgrade to this version or later. Some workarounds are available. Restrict `backend.reading.allow` to only trusted hosts that you control and that do not issue redirects, ensure allowed hosts do not have open redirect vulnerabilities, and/or use network-level controls to block access from Backstage to sensitive internal endpoints.
Backstage is an open framework for building developer portals, and @backstage/cli-common provides config loading functionality used by the backend and command line interface of Backstage. Prior to version 0.1.17, the `resolveSafeChildPath` utility function in `@backstage/backend-plugin-api`, which is used to prevent path traversal attacks, failed to properly validate symlink chains and dangling symlinks. An attacker could bypass the path validation via symlink chains (creating `link1 → link2 → /outside` where intermediate symlinks eventually resolve outside the allowed directory) and dangling symlinks (creating symlinks pointing to non-existent paths outside the base directory, which would later be created during file operations). This function is used by Scaffolder actions and other backend components to ensure file operations stay within designated directories. This vulnerability is fixed in `@backstage/backend-plugin-api` version 0.1.17. Users should upgrade to this version or later. Some workarounds are available. Run Backstage in a containerized environment with limited filesystem access and/or restrict template creation to trusted users.
Backstage is an open framework for building developer portals. Multiple Scaffolder actions and archive extraction utilities were vulnerable to symlink-based path traversal attacks. An attacker with access to create and execute Scaffolder templates could exploit symlinks to read arbitrary files via the `debug:log` action by creating a symlink pointing to sensitive files (e.g., `/etc/passwd`, configuration files, secrets); delete arbitrary files via the `fs:delete` action by creating symlinks pointing outside the workspace, and write files outside the workspace via archive extraction (tar/zip) containing malicious symlinks. This affects any Backstage deployment where users can create or execute Scaffolder templates. This vulnerability is fixed in `@backstage/backend-defaults` versions 0.12.2, 0.13.2, 0.14.1, and 0.15.0; `@backstage/plugin-scaffolder-backend` versions 2.2.2, 3.0.2, and 3.1.1; and `@backstage/plugin-scaffolder-node` versions 0.11.2 and 0.12.3. Users should upgrade to these versions or later. Some workarounds are available. Follow the recommendation in the Backstage Threat Model to limit access to creating and updating templates, restrict who can create and execute Scaffolder templates using the permissions framework, audit existing templates for symlink usage, and/or run Backstage in a containerized environment with limited filesystem access.
FastAPI Api Key provides a backend-agnostic library that provides an API key system. Version 1.1.0 has a timing side-channel vulnerability in verify_key(). The method applied a random delay only on verification failures, allowing an attacker to statistically distinguish valid from invalid API keys by measuring response latencies. With enough repeated requests, an adversary could infer whether a key_id corresponds to a valid key, potentially accelerating brute-force or enumeration attacks. All users relying on verify_key() for API key authentication prior to the fix are affected. Users should upgrade to version 1.1.0 to receive a patch. The patch applies a uniform random delay (min_delay to max_delay) to all responses regardless of outcome, eliminating the timing correlation. Some workarounds are available. Add an application-level fixed delay or random jitter to all authentication responses (success and failure) before the fix is applied and/or use rate limiting to reduce the feasibility of statistical timing attacks.
The Flux Operator is a Kubernetes CRD controller that manages the lifecycle of CNCF Flux CD and the ControlPlane enterprise distribution. Starting in version 0.36.0 and prior to version 0.40.0, a privilege escalation vulnerability exists in the Flux Operator Web UI authentication code that allows an attacker to bypass Kubernetes RBAC impersonation and execute API requests with the operator's service account privileges. In order to be vulnerable, cluster admins must configure the Flux Operator with an OIDC provider that issues tokens lacking the expected claims (e.g., `email`, `groups`), or configure custom CEL expressions that can evaluate to empty values. After OIDC token claims are processed through CEL expressions, there is no validation that the resulting `username` and `groups` values are non-empty. When both values are empty, the Kubernetes client-go library does not add impersonation headers to API requests, causing them to be executed with the flux-operator service account's credentials instead of the authenticated user's limited permissions. This can result in privilege escalation, data exposure, and/or information disclosure. Version 0.40.0 patches the issue.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.